Ethyl Indole-2-Carboxylate CAS 3770-50-1 Purity >98.5% (GC) Factory High Quality

Tlhaloso e Khutšoanyane:

Lebitso la lik'hemik'hale: Ethyl Indole-2-Carboxylate

CAS: 3770-50-1

Bohloeki: >98.5% (GC)

Ponahalo: Bosoeu bo Bosoeu ho isa Bosehla

Boleng bo Phahameng, Tlhahiso ea Khoebo

E-Mail: alvin@ruifuchem.com

Re romelle lengolo-tsoibila

Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Phepelo ea Moetsi ka Boleng bo Phahameng, Tlhahiso ea Khoebo
Lebitso la lik'hemik'hale: Ethyl Indole-2-Carboxylate CAS: 3770-50-1

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale	Ethyl Indole-2-Carboxylate
Litlhaloso tse tšoanang	Indole-2-Carboxylic Acid Ethyl Ester;Ethyl 1H-Indole-2-Carboxylate;2-Ethoxycarbonylindole
Nomoro ea CAS	3770-50-1
Nomoro ea KAtse	RF-PI1481
Boemo ba Setoko	Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane
Foromo ea limolek'hule	C11H11NO2
Boima ba Molek'hule	189.21
Brand	Ruifu Chemical

Litlhaloso:

Ntho	Litlhaloso
Ponahalo	Phofo e Tletseng-Bosoeu ho isa ho Bosehla
Mokhoa oa Bohloeki / Analysis	>98.5% (GC)
Melting Point	115.0 ~ 125.0℃
Tahlehelo ka ho Omisa	≤0.50%
Litšila ka Kakaretso	<1.50%
Tekanyetso ea Teko	Maemo a Khoebo
Tšebeliso	Mekhatlo ea Meriana

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo.

Melemo:

LBH:

Kopo:

Ethyl Indole-2-Carboxylate (CAS: 3770-50-1) ke mohaho oa mohaho o 'nileng oa sebelisoa e le mokhoa oa ho sebetsana le ho lokisoa ha lihlahisoa tsa pyridazinoindole tse nang le mesebetsi ea antimicrobial.E sebelisoa e le li-intermediate tsa meriana ha ho etsoa li-angiotensin converting enzyme inhibitors (ACEIs).Reactant bakeng sa ho lokisetsa: CRTH2 receptor antagonists;Indoleamine 2,3-dioxygenase (IDO) inhibitors;Cannabinoid CB1 receptor antagonists;Li-inhibitors tsa Human Reticulocyte 15-Lipoxygenase-1;N-(benzoylphenyl) -1H-indole-2-carboxamides e le li-antihypertriglyceridemic agents tse matla;Moemeli oa antiproliferative khahlanong le kankere ea mali ea batho lisele tsa K562; Li-inhibitors tsa p38 MAP kinase;Acetolactate synthase inhibitors.